Holen Sie sich die Stockscreener-App
4.74
1.29%
0.08
Schlusskurs vom Vortag:
$4.66
Offen:
$4.75
24-Stunden-Volumen:
14,522
Relative Volume:
0.08
Marktkapitalisierung:
$7.39M
Einnahmen:
$8.62M
Nettoeinkommen (Verlust:
$-6.15M
KGV:
-0.4297
EPS:
-11.03
Netto-Cashflow:
$-5.32M
1W Leistung:
+0.21%
1M Leistung:
-8.70%
6M Leistung:
+113.57%
1J Leistung:
-7.27%
1-Tages-Spanne:
$4.60
$4.79
1-Wochen-Bereich:
$4.3904
$4.88
52-Wochen-Spanne:
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Vergleichen Sie EVOK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
4.74 | 7.26M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
143.28 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.165 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
434.04 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
| 2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
| 2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
| 2016-07-19 | Bestätigt | FBR Capital | Outperform |
| 2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Eingeleitet | Northland Capital | Outperform |
| 2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
| 2014-12-03 | Bestätigt | MLV & Co | Buy |
| 2014-11-07 | Eingeleitet | MLV & Co | Buy |
| 2014-04-22 | Eingeleitet | Laidlaw | Buy |
| 2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
Evoke Pharma Inc.’s volatility index tracking explained2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
How currency fluctuations impact Evoke Pharma Inc. stockJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Does Evoke Pharma Inc. fit your quant trading modelGlobal Markets & Technical Buy Zone Confirmations - newser.com
Real time alert setup for Evoke Pharma Inc. performanceDay Trade & Free Community Consensus Stock Picks - newser.com
Using data tools to time your Evoke Pharma Inc. exitMarket Trend Report & Consistent Income Trade Ideas - newser.com
Short interest data insights for Evoke Pharma Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com
What to expect from Evoke Pharma Inc. in the next 30 daysDay Trade & Daily Profit Maximizing Tips - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Evoke Pharma (NASDAQ:EVOK) - Defense World
Will Evoke Pharma Inc. stock recover after recent drop2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Sector ETF performance correlation with Evoke Pharma Inc.Trade Entry Report & Verified Entry Point Signals - newser.com
Institutional scanner results for Evoke Pharma Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com
Will Evoke Pharma Inc. stock return to pre crisis levelsJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
How to monitor Evoke Pharma Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com
What Fibonacci levels say about Evoke Pharma Inc. rebound2025 Market Overview & Growth Focused Investment Plans - newser.com
Is Evoke Pharma Inc a good long term investmentLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in
News impact scoring models applied to Evoke Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):